GCI Liberty GLIBK Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines OLP Q1 2026 Earnings EPS Surpasses Estimates as Management Highlights Portfolio Performance GALT Q1 2026 Earnings WiderThanExpected Loss as ClinicalStage Biotech Continues RD Spend EVAX Q1 2026 Earnings WiderthanExpected Loss as Biotech Continues Development REAL Q1 2026 Earnings Narrowing Losses as Consignment Volumes Improve ESLA Q1 2026 Earnings WiderThanExpected Loss and No Revenue Highlight DevelopmentStage Challenges